Table 3.1GRADE profile: Does training healthcare professionals on the identification and management of neutropenic sepsis improve outcomes for patients receiving anticancer treatment?

Quality assessmentSummary of findings
Summary of findingsEffectQuality
No of studiesDesignLimitationsInconsistencyIndirectnessImprecisionOther considerationsEnhanced training of healthcare professionals on the identification and management of neutropenic sepsisstandard training of healthcare professionals on the identification and management of neutropenic sepsisRelative
(95% CI)
Absolute
Door-to-needle time (Better indicated by lower values)
2observational studiesvery serious1serious2serious3serious4none163104Not pooledVERY LOW
1

One study is a retrospective study with a high risk of bias and the other study, which is an audit, is only reported in abstract form and can therefore not be comprehensively evaluated

2

The studies report different results, both statistically and numerically.

3

The interventions are under-specified in the studies.

4

The sample sizes were small in both studies.

From: 3, Information, support and training

Cover of Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
NICE Clinical Guidelines, No. 151.
National Collaborating Centre for Cancer (UK).
Copyright © National Collaborating Centre for Cancer, 2012.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.